A PBM Disclosure Rule Is Not a Readiness Plan
A new disclosure requirement can create the illusion that the important work belongs to the vendor. It does not. A report can arrive on time and still be useless if nobody has decided who receives it, what gets tested, and what happens when the answers do not fit the contract or the plan’s expectations.
For a self-funded employer, transparency is not the finish line. It is an input to a purchasing and fiduciary process.
The source idea: more information is coming
In October 2026, the U.S. Department of Labor finalized a rule requiring detailed compensation disclosures from covered providers of pharmacy benefit management services to large self-insured group health plans. The Department says the rule generally reaches self-insured plans with at least 100 participants or offered by employers with at least 100 employees, subject to the rule’s terms and exceptions. It describes both initial and ongoing disclosures, along with a fiduciary’s ability to audit the information for accuracy.
The compliance date matters, but the management lesson matters sooner. A plan should not wait for its first required disclosure to decide how pharmacy information will move from an inbox to a business decision.
Build the receiving end before the report arrives
Start with the plan’s own structure. Identify the named fiduciary or committee that needs the information, the operational person who will coordinate requests, and the finance leader who can connect pharmacy findings to the budget. An advisor, counsel, or independent reviewer may help, but outside help does not replace a clear employer decision owner.
Then define the questions. Compensation is one question, not the whole review. Leadership may also need to understand whether the formulary changed, whether specialty utilization shifted, what employees experienced at the pharmacy counter, and whether the contract explains the amounts shown. A large spreadsheet without a question set can become a storage project instead of a review.
Put the review on the renewal calendar
For many Midwest employers, pharmacy decisions are made on a renewal rhythm. That makes timing part of the control. If a plan needs to consider a contract change, a different clinical approach, or a vendor alternative, the information must be available early enough to evaluate those choices without forcing a rushed transition on employees.
Set a calendar that works backward from renewal: when disclosures are due, when questions go to the service provider, when the response will be reviewed, and who can authorize an escalation. This is also the time to decide what records will be retained. An unexplained variance is not proof of wrongdoing. It is a signal to ask for the contract, calculation, and operational explanation before drawing a conclusion.
Use disclosure as a decision file
Paul H. Flowers Jr. at Superior Insurance Advisors and Paul.Health helps employers organize a practical health-plan decision file: what the vendor promised, what the available evidence shows, what remains unknown, and what action is actually available. With pharmacy benefits, that discipline is especially useful because financial, clinical, member-service, and contract questions are often spread across different people and reports.
A disclosure rule can make the information more available. It does not automatically make the information comparable, timely, or actionable. Those are employer choices.
Source: U.S. Department of Labor, “Pharmacy Benefit Manager Fee Disclosure Final Rule”, October 2026, accessed November 13, 2026. This article is original educational commentary, not legal, tax, investment, or fiduciary advice. The final rule, plan documents, contracts, and applicable law govern.
Five readiness questions before the first disclosure
- Which plan fiduciary or committee is accountable for receiving and evaluating pharmacy disclosures?
- What contract terms, renewal assumptions, and pharmacy measures will the plan compare against the report?
- How early must information arrive for leadership to consider a meaningful change?
- Who will request clarification and preserve the vendor’s explanation when a result is unclear?
- What decision can the team make after review: monitor, negotiate, audit, change the contract, or test an alternative?
If a detailed PBM disclosure arrived tomorrow, would your team know who owns the next question and when it must be answered?